ReviewAdvanced healthcare materials2026
Liquid Metal Materials for Tumor Diagnosis and Treatment.
Review in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Liquid metals (LMs) represent a novel category of functional materials characterized by low melting points, metallic conductivity, and distinctive fluidic behavior. In contrast to traditional metals, LMs exhibit a combination of mechanical flexibility alongside superior electrical conductivity and thermal properties, rendering them highly suitable for biomedical applications. Ga-based LMs, in particular, have attracted significant interest due to their favorable biocompatibility and chemical stability, effectively addressing the toxicity concerns associated with mercury. In the context of tumor diagnosis, their elevated X-ray attenuation coefficients and facile surface modification capabilities enable their use as contrast-enhancing agents in X-ray imaging, computed tomography, and photoacoustic imaging modalities. Therapeutically, Ga-based LMs have been investigated for their potential as antimicrobial agents, drug delivery vehicles, and multifunctional composites in cancer treatment. Taken together, the combination of deformability, electrical conductivity, and biocompatibility underscores the potential of LMs as promising candidates for next-generation theranostic platforms. This review provides an overview of the fundamental properties of LMs and discusses recent progress in their application for tumor diagnosis and therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.